Literature DB >> 6283138

Carboxy-terminal analysis of poliovirus proteins: termination of poliovirus RNA translation and location of unique poliovirus polyprotein cleavage sites.

E A Emini, M Elzinga, E Wimmer.   

Abstract

The carboxy-terminal amino acids of a number of poliovirus proteins were determined by carboxypeptidase A analysis. The nonstructural proteins P3-2, P3-4b and their precursor. P3-1b, were found to be coterminal with a sequence of -Ser-Phe-COOH. As these proteins are coded for at the extreme 3' end of the viral RNA, it is possible to establish the termination site of translation at nucleotide 7,361, 73 nucleotides before the start of the polyadenylic acid tract of the RNA. Two additional nonstructural proteins, P2-X and its precursor, P2-3b, were also found to be coterminal with a sequence of -Phe-Gln-COOH. This result confirms the existence of at least one Gln-Gly proteolytic cleavage site. These Gln-Gly cleavage sites are predicted from the nucleotide sequence to be ubiquitous throughout the poliovirus genome. The only exceptions are the cleavage sites at the carboxy termini of the structural protein VP4 and VP1. Carboxypeptidase A analysis of VP1 establishes a terminal sequence of -Thr-Tyr-COOH, and similar analysis of VP4 shows Asn to be the terminal amino acid residue, observations that prove the existence of the exceptional C-terminal amino acids. In none of the analyzed cases has C-terminal trimming after cleavage been observed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6283138      PMCID: PMC256060     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  The genome of poliovirus is an exceptional eukaryotic mRNA.

Authors:  Y F Lee; A Nomoto; E Wimmer
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1976

2.  The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg.

Authors:  A Nomoto; N Kitamura; F Golini; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

3.  Characterization of the large picornaviral polypeptides produced in the presence of zinc ion.

Authors:  B E Butterworth; B D Korant
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

4.  Polypeptide cleavages in the formation of poliovirus proteins.

Authors:  M F Jacobson; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

5.  Evidence for large precursor proteins in poliovirus synthesis.

Authors:  D F Summers; J V Maizel
Journal:  Proc Natl Acad Sci U S A       Date:  1968-03       Impact factor: 11.205

6.  Specific cleavage of viral proteins as steps in the synthesis and maturation of enteroviruses.

Authors:  J J Holland; E D Kiehn
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

7.  Polyadenylic acid at the 3'-terminus of poliovirus RNA.

Authors:  Y Yogo; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

8.  Alignment of the peptides derived from acid-catalyzed cleavage of an aspartylprolyl bond in the major internal structural polypeptide of avian retroviruses.

Authors:  A S Bhown; J C Bennett; E Hunter
Journal:  J Biol Chem       Date:  1980-07-25       Impact factor: 5.157

9.  A protein covalently linked to poliovirus genome RNA.

Authors:  Y F Lee; A Nomoto; B M Detjen; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

10.  Polyadenylic acid sequences in the virion RNA of poliovirus and Eastern Equine Encephalitis virus.

Authors:  J A Armstrong; M Edmonds; H Nakazato; B A Phillips; M H Vaughn
Journal:  Science       Date:  1972-05-05       Impact factor: 47.728

View more
  18 in total

1.  Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase.

Authors:  W S Blair; B L Semler
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

2.  Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification.

Authors:  M S Oberste; K Maher; D R Kilpatrick; M A Pallansch
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

3.  A mutant poliovirus containing a novel proteolytic cleavage site in VP3 is altered in viral maturation.

Authors:  W S Blair; S S Hwang; M F Ypma-Wong; B L Semler
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  Cleavage of a viral polyprotein by a cellular proteolytic activity.

Authors:  Y C Tian; D S Shih
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

5.  A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation.

Authors:  S K Jang; H G Kräusslich; M J Nicklin; G M Duke; A C Palmenberg; E Wimmer
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

6.  A cellular cofactor facilitates efficient 3CD cleavage of the poliovirus P1 precursor.

Authors:  W S Blair; X Li; B L Semler
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

7.  Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors.

Authors:  A Molla; C U Hellen; E Wimmer
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Identification of a new neutralization antigenic site on poliovirus coat protein VP2.

Authors:  E A Emini; B A Jameson; E Wimmer
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

9.  Similarity in gene organization and homology between proteins of animal picornaviruses and a plant comovirus suggest common ancestry of these virus families.

Authors:  P Argos; G Kamer; M J Nicklin; E Wimmer
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

10.  Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs.

Authors:  R Hanecak; B L Semler; C W Anderson; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.